ACM
RCUS icon

Aquatic Capital Management’s Arcus Biosciences RCUS Stock Holding History

Aquatic Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,297
Closed -$330K – 1645
2026
Q1 		$330K Sell
15,297
-12,707
-45% -$274K 0.01% 875
2025
Q4 		$667K Buy
+28,004
New +$571K 0.02% 660
2024
Q4 		– Sell
-3,600
Closed -$55K – 1562
2024
Q3 		$55K Sell
3,600
-2,200
-38% -$34.7K ﹤0.01% 989
2024
Q2 		$88.3K Buy
+5,800
New +$93.6K ﹤0.01% 919
2023
Q4 		– Sell
-7,800
Closed -$140K – 1573
2023
Q3 		$140K Buy
+7,800
New +$157K 0.01% 761
2023
Q1 		– Sell
-9,400
Closed -$194K – 1672
2022
Q4 		$194K Buy
+9,400
New +$259K 0.01% 743

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Aquatic Capital Management's RCUS Position: Q2 2026 in Review

Aquatic Capital Management sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 15,297 shares — an estimated $330K sold.

Aquatic Capital Management first reported a position in RCUS in Q4 2022 and held it in 6 quarters. The position peaked at $667K in Q4 2025. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Aquatic Capital Management reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 15,297 Arcus Biosciences shares in Q2 2026, an estimated $330K.
  • Aquatic Capital Management first reported a position in Arcus Biosciences in Q4 2022 and held it in 6 quarters.
  • Aquatic Capital Management's Arcus Biosciences position peaked at $667K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.